Loto Biotech is a biotech startup developing a proprietary AI-driven platform to design siRNA-based pro-drugs for rare genetic disorders, with a focus on autosomal dominant diseases.
Loto Biotech has raised €600k across 1 funding round from 1 investor, most recently a round in Jun 2025. Based in L’Aquila, Italy; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-06-30 | Other | €600k |
| Scientifica Venture Capital |
| View deal → |
